Insider Transactions in Q1 2021 at Constellation Pharmaceuticals Inc (CNST)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2021
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
14,987
+50.0%
|
-
|
|
Feb 22
2021
|
Emma Reeve Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,260
-100.0%
|
$231,620
$37.6 P/Share
|
|
Feb 22
2021
|
Emma Reeve Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,260
+50.0%
|
$50,080
$8.04 P/Share
|
|
Feb 19
2021
|
Emma Reeve Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,010
-100.0%
|
$148,370
$37.71 P/Share
|
|
Feb 19
2021
|
Emma Reeve Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,010
+50.0%
|
$32,080
$8.04 P/Share
|
|
Feb 18
2021
|
Emma Reeve Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,100
-100.0%
|
$40,700
$37.58 P/Share
|
|
Feb 18
2021
|
Emma Reeve Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+50.0%
|
$8,800
$8.04 P/Share
|
|
Feb 17
2021
|
Emma Reeve Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
410
-100.0%
|
$15,170
$37.56 P/Share
|
|
Feb 17
2021
|
Emma Reeve Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
410
+50.0%
|
$3,280
$8.04 P/Share
|
|
Feb 17
2021
|
Column Group L P > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,000
-9.16%
|
$720,000
$36.95 P/Share
|
|
Jan 19
2021
|
Karen Valentine |
SELL
Open market or private sale
|
Direct |
17,203
-55.18%
|
$567,699
$33.96 P/Share
|
|
Jan 19
2021
|
Karen Valentine |
BUY
Exercise of conversion of derivative security
|
Direct |
17,203
+50.0%
|
$189,233
$11.5 P/Share
|